RA Capital Management »

Prime Medicine shares owned by RA Capital Management

Quarter-by-quarter ownership of Prime Medicine (PRME) shares owned by RA Capital Management from 13F filings

Historical chart of RA Capital Management investment in Prime Medicine

Tip: Access up to 7 years of quarterly data

All positions including Prime Medicine held by RA Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Prime Medicine by RA Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $17M 3.0M 5.54

More positions owned by RA Capital Management

Ascendis Pharma A/s - SH (ASND)
Rhythm Pharmaceuticals SH (RYTM)
Vaxcyte SH (PCVX)
Avidity Biosciences SH (RNA)
Cidara Therapeutics SH (CDTX)
Sionna Therapeutics SH (SION)
89bio SH (ETNB)
Newamsterdam Pharma Co Nv SH (NAMS)
Mineralys Therapeutics SH (MLYS)
Janux Therapeutics SH (JANX)
Arcellx SH (ACLX)
Lenz Therapeutics SH (LENZ)
Tyra Biosciences SH (TYRA)
Edgewise Therapeutics SH (EWTX)
Wave Life Sciences SH (WVE)

View all positions for RA Capital Management

Top funds holding Prime Medicine

Alphabet
T. Rowe Price Investment Management
BlackRock
ARK Investment Management
Vanguard Group
Farallon Capital Management
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Casdin Capital
Woodline Partners
RA Capital Management
FMR
D. E. Shaw & Co
MWG Management
Geode Capital Management

View all funds holding Prime Medicine